Mark J. Graham
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Peroxisome Proliferator-Activated Receptors 15
- Surgery 45
- Lipoproteins and Cardiovascular Health 17
- Cholesterol and Lipid Metabolism 16
- Co-authors
- Rosanne M. Crooke (71 shared papers)Richard Lee (23 shared papers)Brenda F. Baker (12 shared papers)Richard S. Geary (8 shared papers)Joseph L. Witztum (8 shared papers)Steven G. Hughes (6 shared papers)Brett P. Monia (3 shared papers)Sotirios Tsimikas (6 shared papers)
- Journals
- Journal of Lipid Research (15 papers)Cell Metabolism (8 papers)Arteriosclerosis Thrombosis and Vascular Biology (8 papers)Journal of Biological Chemistry (6 papers)PLoS ONE (6 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Mark J. Graham
153 papers receiving 13.5k citations
Mark J. Graham's Hit Papers
Peers
Comparison fields: 5 of 152
- Cancer Research 2.9k
- Endocrinology, Diabetes and Metabolism 2.6k
- Biochemistry 989
- Cardiology and Cardiovascular Medicine 2.4k
- Molecular Biology 6.4k
Countries citing papers authored by Mark J. Graham
This map shows the geographic impact of Mark J. Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Graham more than expected).
Fields of papers citing papers by Mark J. Graham
This network shows the impact of papers produced by Mark J. Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Graham. The network helps show where Mark J. Graham may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark J. Graham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 154 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting Hit paper breakdown → | 2006 | 1717 |
| 2 | Trimethylamine-N-Oxide, a Metabolite Associated with Atherosclerosis, Exhibits Complex Genetic and Dietary Regulation Hit paper breakdown → | 2013 | 812 |
| 3 | Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials Hit paper breakdown → | 2016 | 544 |
| 4 | Targeted delivery of antisense oligonucleotides to hepatocytes using triantennaryN-acetyl galactosamine improves potency 10-fold in mice Hit paper breakdown → | 2014 | 468 |
| 5 | Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides Hit paper breakdown → | 2017 | 454 |
| 6 | Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia Hit paper breakdown → | 2015 | 409 |
| 7 | Targeting APOC3 in the Familial Chylomicronemia Syndrome Hit paper breakdown → | 2014 | 381 |
| 8 | Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study Hit paper breakdown → | 2015 | 358 |
| 9 | 2015 | 298 | |
| 10 | 2013 | 297 | |
| 11 | Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction Hit paper breakdown → | 2019 | 296 |
| 12 | 2006 | 285 | |
| 13 | 2012 | 273 | |
| 14 | 2014 | 269 | |
| 15 | 1990 | 258 | |
| 16 | 2007 | 238 | |
| 17 | 2018 | 194 | |
| 18 | 2016 | 193 | |
| 19 | 2005 | 179 | |
| 20 | 2014 | 164 |
About Mark J. Graham
Mark J. Graham is a scholar working on Molecular Biology, Surgery, Epidemiology, Endocrinology, Diabetes and Metabolism and Physiology, having authored 154 papers that have together received 13.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (20 papers), Lipid metabolism and biosynthesis (17 papers), Lipoproteins and Cardiovascular Health (17 papers), Cholesterol and Lipid Metabolism (16 papers), Lipid metabolism and disorders (16 papers), Peroxisome Proliferator-Activated Receptors (15 papers), Adipose Tissue and Metabolism (14 papers) and Drug Transport and Resistance Mechanisms (13 papers). The work is most often cited by research in Cancer Research (2.9k citations), Endocrinology, Diabetes and Metabolism (2.6k citations), Biochemistry (989 citations), Cardiology and Cardiovascular Medicine (2.4k citations) and Molecular Biology (6.4k citations). Mark J. Graham has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Rosanne M. Crooke, Richard Lee, Brenda F. Baker, Richard S. Geary, Joseph L. Witztum, Steven G. Hughes, Brett P. Monia, Sotirios Tsimikas, Stanley T. Crooke and W. S. Singleton. Their work appears in journals such as Journal of Lipid Research, Cell Metabolism, Arteriosclerosis Thrombosis and Vascular Biology, Journal of Biological Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.